Moderna Inc.

(MRNA) Trade

Symbol has changed to a new ticker symbol

(ATRX)

By |

Profile

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. Its therapeutic and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company's approach is to use mRNA medicines to instruct a patient's own cells to produce proteins that could prevent, treat, or cure disease.

Contact Information

Website: www.modernatx.com
Email: ir@marinabio.com
Main Phone: +1 617 714-6500
Address: 200 Technology Square
Address 2: Suite 250
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Stephane Bancel
Employees: 700
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 18.76 $ 0.08 (0.43%)
Last Price 18.76 Change $ 0.08 Change % 0.43 Tick N/A
Bid 18.15 Bid Size 100.00 Ask 19.29 Ask Size 100.00
Open 19.25 High 19.29 Low 18.68 Prev Close 18.68
Last Trade Volume 1.6 mi 52 Wk Hi 22.75 52 Wk Low 17.99
Market Cap 6.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 328,948,088.00 EPS (TTM) -1.03 PE Ratio N/A Exchange NGS
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1